Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
477.37
+5.37 (+1.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,181,338
Open
474.03
Bid (Size)
465.00 (1)
Ask (Size)
480.00 (3)
Prev. Close
472.00
Today's Range
469.91 - 477.67
52wk Range
340.83 - 510.63
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Fantastic Growth Stocks to Buy in August
Today 7:30 EDT
These stocks should keep up their winning ways.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
Performance
YTD
+16.17%
+16.17%
1 Month
-2.25%
-2.25%
3 Month
+7.22%
+7.22%
6 Month
+13.07%
+13.07%
1 Year
+38.82%
+38.82%
More News
Read More
3 Biotech Stocks to Buy on the Dip: August 2024
August 15, 2024
Via
InvestorPlace
Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them
August 15, 2024
Via
The Motley Fool
2 Biotech Stocks to Buy Hand Over Fist in August
August 12, 2024
Via
The Motley Fool
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
August 09, 2024
Via
Benzinga
Vertex Slumps On Light Second-Quarter Despite Hiked 2024 Outlook
August 01, 2024
Via
Investor's Business Daily
The 3 Best Biotech Stocks to Buy in August 2024
August 08, 2024
Via
InvestorPlace
Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England
August 07, 2024
From
Vertex Pharmaceuticals
Via
Business Wire
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
August 05, 2024
Via
The Motley Fool
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
August 04, 2024
Via
InvestorPlace
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
August 04, 2024
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
Via
The Motley Fool
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
August 03, 2024
Via
The Motley Fool
3 Biotech Stocks That Could Have Investors Grinning Soon
August 02, 2024
Via
InvestorPlace
Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?
August 02, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline
August 02, 2024
Via
Benzinga
Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.
August 02, 2024
Via
The Motley Fool
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
August 01, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Vertex Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
August 01, 2024
Via
The Motley Fool
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
August 01, 2024
Via
Benzinga
The Top 3 Biotech Stocks to Buy Now Summer 2024
July 31, 2024
Via
InvestorPlace
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
August 01, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.